Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach
-
Published:2021
Issue:
Volume:26
Page:100745
-
ISSN:2352-9148
-
Container-title:Informatics in Medicine Unlocked
-
language:en
-
Short-container-title:Informatics in Medicine Unlocked
Author:
Shahabadi NahidORCID,
Zendehcheshm Saba,
Mahdavi Mohammad,
Khademi Fatemeh
Subject
Health Informatics
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献